In HCV infection, the TGF-β signaling pathway is altered, resulting in the progression of liver injury, the tumor suppressor activity of TGF-β changes to fibrogenic leading to the risk of HC, IL-1, IL-23, IL-6 and lymphotoxins were involved in the development and progression of inflammation in HC.73 This evidence concerns the gene TGFB1 and neoplasm.